SecBot SecBot

GMED

GLOBUS MEDICAL INC
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001237831 Healthcare & Medical Devices
$81.83 +0.42 (+0.52%)
Oct 26 4:00 PM ET · prev $81.41
Market cap
$11.0B
Large cap
Consensus
Buy
70% Buy or better · 23 analysts
Median target
$100.00
+22% · range $84.00–125.00
Next earnings
Nov 5
in 10 days
1 year
+29.4%
from $63.26 · Oct 27
30 days
+9.4%
from $74.78
52-week range
$60.39–96.82
−15% from high · low Oct 31
Avg volume 20D
1.41M
shares / day
Short interest
8.44M
≈6.3% of shares · +24.7%
Days to cover
5.1
at average volume
Insider net
−$9.2M
0 buyers · 4 sellers · 12 mo
New fund stakes
5
Q2 2026 13F · 4 exits
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 1 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 2/4 ·Next Earnings date, Nov 5, 2026
Strongest BULLISH The Federal Circuit affirmed summary judgment of noninfringement for Globus Medical on three spine-surgery…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    4 insiders sold $9.2M.

  • InstitutionsBULLISH

    Q2 2026: 49 added (5 new), 23 trimmed or exited. Largest new: Kayne Anderson Rudnick Investment Management $338.1M, Boston Partners $122.8M.

  • AnalystsBULLISH

    16 of 23 rate it Buy or better. Every target is above the price.

  • Short sellersBUILDING

    Short interest +24.7% to 8.44M shares. 5.1 days to cover, ≈6.3% of shares.

  • TrendUPTREND

    5% above its 50-day average.

Who's buying

13F· Q2 2026
5
new positions
4
exits
$524.8M
in new stakes
FundMoveSharesValue
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLCNEW4,279,730$338.1M
ALLIANCEBERNSTEIN L.P.ADD2,380,344$205.1M
DIMENSIONAL FUND ADVISORS LPADD2,369,310$187.3M
GOLDMAN SACHS GROUP INCADD1,781,608$140.8M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD1,716,621$135.6M
Boston Trust Walden CorpADD1,573,361$124.3M
Boston PartnersNEW1,554,990$122.8M
Allspring Global Investments Holdings, LLCDOUBLED1,571,681$119.4M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

23 analysts
Buy 70% rate it Buy or better
Strong Buy4Buy12Hold7Sell0Strong Sell0
12-month targets · 13 analysts

Price is below the lowest target. Median implies +22%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Oct 1, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Aug 7, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Jul 28, 2026UBS
INITIATE
INITIATENeutral
Jul 16, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Jul 13, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Jul 9, 2026BMO Capital
INITIATE
INITIATEOutperform

Insider ledger

Form 4
$0
bought · 0 insiders
$9.2M
sold · 4 insiders
DateInsiderTypeValue
Sep 15, 2026
TOBIN JAMES R
Director
SELL$2.2M
Sep 15, 2026
TOBIN JAMES R
Director
EXERCISE$955.2K
Sep 15, 2026
TOBIN JAMES R
Director
EXERCISE$806.3K
Aug 18, 2026
ZARRILLI STEPHEN T
Director
EXERCISE$1.3M
Aug 18, 2026
ZARRILLI STEPHEN T
Director
SELL$2.2M
Jul 27, 2026
Davidar David D
Director
GIFT2,500 sh
Jun 5, 2026
Davidar David D
Director
EXERCISE$656.8K
Jun 5, 2026
Davidar David D
Director
SELL$2.0M

Earnings setup

Estimates
Nov 5
reports in 10 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Congressional trades
GMED trades disclosed by members of Congress, with disclosure delay.
1 members(excl. 1 subscriber-only trade) · 3 buys / 0 sells
DateMemberTypeAmountDisclosed
Sep 3, 2026
Gilbert Cisneros
D· HOUSE· Globus Medical Inc
BUY$1,001 - $15,000Oct 12, 2026(39d)
Aug 19, 2026
Gilbert Cisneros
D· HOUSE· Globus Medical Inc
BUY$15,001 - $50,000Sep 10, 2026(22d)
Mar 3, 2026🔒 Fresh data, subscribers onlyBUY

Short side

FINRA· Sep 30, 2026
8,437,114
shares short
+24.7%
vs prior settlement
5.1
days to cover
≈6.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 21, 2026 Other
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves
Oct 21, 2026 SEC
Three asset managers modestly added to GMED positions in Q3 2026, while one trimmed. The net buying is small in…
INST-CLUSTER — Impact 3/10
Sep 15, 2026 SEC
Director James R. Tobin filed a Form 144 notice to sell 30,000 GMED shares via a cashless option exercise, with an…
144 — Impact 2/10
Sep 15, 2026 Insider
TOBIN JAMES R sold 30,000 shares
Director @ $74.58 ($2.2M)
Sep 15, 2026 Insider
TOBIN JAMES R acquired via exercise 15,000 shares
Director @ $63.68 ($955.2K)
Sep 15, 2026 Insider
TOBIN JAMES R acquired via exercise 15,000 shares
Director @ $53.75 ($806.3K)
Sep 11, 2026 SEC
The Federal Circuit affirmed summary judgment of noninfringement for Globus Medical on three spine-surgery patents…
COURT-RULING — Impact 6/10
Sep 11, 2026 Event
Moskowitz Family LLC v. Globus Medical, Inc.
Court ruling (ca13) — Docket: 24-01696
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
GMED Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Oct 21, 2026
Press release
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors…
Sep 30, 2026
Short interest
Short Interest: GMED up 25% to 8.4M shares
Settlement 2026-09-30 | Days to cover: 5.14 | ≈6.28% of shares outstanding (est.)
Sep 11, 2026
Enforcement
Moskowitz Family LLC v. Globus Medical, Inc.
Court ruling (ca13) — Docket: 24-01696
Aug 26, 2026
M&A
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the…
Aug 6, 2026
Earnings date
GMED Q2 2026 Earnings Scheduled — 2026-08-06

SecBot reports

8 filings · 1 press release · 2 bullish · 1 bearish · 5 neutral
All GMED filing & press-release reports (9)